Updated Results Of A Prospective, Randomized Comparison Of Two Doses Of Combination Alkylating Agents (Aa) As Consolidation After Caf In High-Risk Primary Breast Cancer Involving Ten Or More Axillary Lymph Nodes (Ln): CALGB 9082/SWOG 9114/NCIC Ma-13. - Peters,W.P.; Rosner,G.; Vredenburgh,J.; Shpall,E.J. (Proc Am Soc Clin Oncol, 2001)